Clinical Application Study of Wearable Multi-channel Electrocardiogram Acquisition Equipment in the Diagnosis of Myocardial Ischemia in Patients with Suspected CHD
Not yet recruiting
- Conditions
- Wearable Electronic DevicesCoronary Arterial Disease (CAD)Myocardial Ischaemia
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 107
- Registration Number
- NCT06868940
Akkermansia Probiotics Plus Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer
Not Applicable
Active, not recruiting
- Conditions
- Colo-rectal CancerPD-1 InhibitorAkkermansia Muciniphila
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 22
- Registration Number
- NCT06865521
- Locations
- 🇨🇳
Colorectal Cancer, West China Hospital, Chengdu, Sichuan, China
Clinical Outcomes of Tislelizumab Combined with Chemotherapy As Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC
Not yet recruiting
- Conditions
- NSCLC Stage IIIB, NSCLC Stage IIIC
- First Posted Date
- 2025-02-17
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06829641
Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma
Phase 2
Recruiting
- Conditions
- Adrenal Cortical CarcinomaAdrenal Cortical CancerAdrenal Cancer
- Interventions
- First Posted Date
- 2025-02-17
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 28
- Registration Number
- NCT06831175
- Locations
- 🇨🇳
West China Hospital, Chengdu, Sichuan, China
Predicting Tumor Origin Based on Deep Learning of Lymph Node Puncture Cytology
Recruiting
- Conditions
- Lymph Nodes With Tumor Metastasis
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT06810349
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, Sichuan, China
Incremental and Decremental PEEP Titration by Diverse Strategies in Subjects with ARDS: a Prospective Physiological Study
Completed
- Conditions
- ARDS
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 31
- Registration Number
- NCT06808438
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, Chengdu, Sichuan, China
Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid Cancer
Not Applicable
Not yet recruiting
- Conditions
- Thyroid CancerRegret
- First Posted Date
- 2025-02-03
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 600
- Registration Number
- NCT06804863
- Locations
- 🇨🇳
West China Hospital, Chengdu, Sichuan, China
Neoadjuvant Low-Dose Radiotherapy Plus Targeted-Immunotherapy vs Targeted-Immunotherapy Monotherapy in Resectable HNSCC: A Randomized Trial
Phase 2
Recruiting
- Conditions
- Head and Neck Cancer
- Interventions
- First Posted Date
- 2025-02-03
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 98
- Registration Number
- NCT06804850
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
A Study of Online Follow-up in Patients with Papillary Thyroid Cancer
Not Applicable
Recruiting
- Conditions
- ThyroidPapillary Thyroid Cancer
- First Posted Date
- 2025-01-30
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 388
- Registration Number
- NCT06800482
- Locations
- 🇨🇳
West China Hospital, Chengdu, Sichuan, China
InclisiRan for Early Passivation of VulneRable AthEroSclerotic PlaqueS in Patients with Acute Coronary Syndromes（REPRESS）
- First Posted Date
- 2025-01-24
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT06791031
© Copyright 2025. All Rights Reserved by MedPath